Granules opens packaging facility in US’ Virginia
Hyderabad-based pharma major, over a period, has invested more than $100 mn in the country
image for illustrative purpose
Washington: Hyderabad-based pharmaceutical company Granules has opened a packaging facility in the Virginia State of the US to expand the packaging capacity of essential drugs in the State, thus strengthening the biopharma supply chain. The facility was inaugurated by India’s Ambassador to the US Taranjit Singh Sandhu.
Granules, which was one of the first Indian pharmaceutical companies that received FDA authorization to export to the United States, has invested more than $100 million in the country, said Dr Krishna Prasad Chigurupati, the founder, chairman and managing director of the firm. “We have nearly 200 employees in Virginia with a large majority of them first-generation Indians,” he said, adding the company also has a team of 30 scientists for research and development.
Granules India Ltd produces some of the most widely used drugs, including Paracetamol, that have been very useful to billions across the world, Chigurupati said. “Happy to see ‘Made in India’ medicines value added in the US by Granules. A perfect example of the India-US partnership in affordable healthcare!”
